Page last updated: 2024-08-21

isoxazoles and Thyroid Cancer, Anaplastic

isoxazoles has been researched along with Thyroid Cancer, Anaplastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, MG; Ihm, SH; Kang, JG; Kim, CS; Kim, SH; Lee, SJ; Yoo, HJ	1

Other Studies

1 other study(ies) available for isoxazoles and Thyroid Cancer, Anaplastic

Article	Year
Novel heat shock protein 90 inhibitor NVP-AUY922 synergizes with the histone deacetylase inhibitor PXD101 in induction of death of anaplastic thyroid carcinoma cells. The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Cell Death; Cell Line, Tumor; Drug Synergism; Histone Deacetylase Inhibitors; HSP90 Heat-Shock Proteins; Humans; Hydroxamic Acids; Isoxazoles; Phosphorylation; Resorcinols; Signal Transduction; Sulfonamides; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms	2015

Article

Year

Novel heat shock protein 90 inhibitor NVP-AUY922 synergizes with the histone deacetylase inhibitor PXD101 in induction of death of anaplastic thyroid carcinoma cells.

The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:2

Topics: Antineoplastic Agents; Apoptosis; Cell Death; Cell Line, Tumor; Drug Synergism; Histone Deacetylase Inhibitors; HSP90 Heat-Shock Proteins; Humans; Hydroxamic Acids; Isoxazoles; Phosphorylation; Resorcinols; Signal Transduction; Sulfonamides; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms

2015